Brawn Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 3.30 | 4.06 | 3.53 |
| Operating Expense | 3.61 | 4.57 | 3.84 |
| Net Profit | -0.34 | -0.53 | -0.34 |
| Net Profit Margin | -10.30 | -13.05 | -9.63 |
| Earning Per Share | -0.96 | -1.83 | -1.12 |
| EBIDTA | -0.31 | -0.50 | -0.31 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 3.30 |
| Operating Expense | 3.61 |
| Net Profit | -0.34 |
| Net Profit Margin | -10.30 |
| Earning Per Share | -0.96 |
| EBIDTA | -0.31 |
| Effective Tax Rate | TBA |
Invest in Brawn Biotech Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 16.49 | 22.23 | 8.62 |
| Operating Expenses Annual | 18.02 | 22.53 | 10.63 |
| Operating Profit Annual | -1.44 | -0.29 | -2.00 |
| Interest Annual | 0.00 | 0.01 | 0.06 |
| Depreciation | 0.10 | 0.11 | 0.05 |
| Net Profit Annual | -1.25 | -0.87 | -1.64 |
| Tax Annual | -0.30 | 0.46 | -0.47 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 16.49 |
| Operating Expenses Annual | 18.02 |
| Operating Profit Annual | -1.44 |
| Interest Annual | 0.00 |
| Depreciation | 0.10 |
| Net Profit Annual | -1.25 |
| Tax Annual | -0.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.44 | 0.22 | 0.40 |
| Cash Flow from Operations | -0.03 | 0.32 | 0.19 |
| Cash Flow from Investing | -0.01 | -0.10 | -0.30 |
| Cash Flow from Financing | TBA | -0.01 | -0.06 |
| Cash Flow at the End | 0.40 | 0.44 | 0.22 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.44 |
| Cash Flow from Operations | -0.03 |
| Cash Flow from Investing | -0.01 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -8.37 | -1.30 | -23.20 |
| PBIT Margin (%) | -8.98 | -1.80 | -23.78 |
| PBT Margin (%) | 141.60 | 178.14 | 372.62 |
| Net PROFIT Margin (%) | -7.58 | -3.91 | -19.03 |
| Return On Networth / Equity (%) | TBA | -12.86 | -20.49 |
| Return On Networth /Employed (%) | TBA | -5.74 | -24.95 |
| Return On Assets (%) | -17.21 | -12.48 | -19.98 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 2.27 | 3.19 | 1.05 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -8.37 |
| PBIT Margin (%) | -8.98 |
| PBT Margin (%) | 141.60 |
| Net PROFIT Margin (%) | -7.58 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -17.21 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 2.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.33 | 0.37 | 0.39 |
| Total Current Assets Annual | 13.14 | 13.40 | 12.19 |
| Non Current Assets Annual | 1.45 | 1.13 | 1.60 |
| Total Shareholders Funds Annual | 5.07 | 6.31 | 7.22 |
| Total Assets Annual | 14.59 | 14.53 | 13.78 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.33 |
| Total Current Assets Annual | 13.14 |
| Non Current Assets Annual | 1.45 |
| Total Shareholders Funds Annual | 5.07 |
| Total Assets Annual | 14.59 |
EPS (INR)
Expected
0.00
Reported
-0.08
Surprise
0.00%
Mar 2023
EPS beaten by 0.00%
Jun 2022
EPS beaten by 0.00%
